China CAS:28721-07-5 Manufacturer

We not only will try our greatest to offer superb companies to just about every buyer, but also are ready to receive any suggestion offered by our shoppers for CAS:28721-07-5, We are going to do our best to fulfill your specifications and are sincerely searching forward to building mutual valuable organization romantic relationship along with you!
CAS:28721-07-5, Welcome to visit our company and factory, there are various solutions displayed in our showroom that will meet your expectation, meanwhile, if you are convenient to visit our website, our sales staff will try their efforts to deliver you the best service

Hot Products

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Nintedanib Esylate

    Nintedanib Esylate

    Nintedanib Esylate has in-house specification. DMF available.

    CAS:656247-18-6

  • Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30
    Indications:Gastric ulcer
  • Levonorgestrel Capsules

    Levonorgestrel Capsules

    Levonorgestrel Capsules Specifications:0.75mg*2
    Indications:Emergency Contraceptive
  • Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3
    Specifications:0.2mg*3
    Indications:Abortion
  • Methylprednisolone Hemisuccinate

    Methylprednisolone Hemisuccinate

    For Methylprednisolone Hemisuccinate, we have EP, USP and CP specification. DMF and WC available.

    CAS:2921-57-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept